{"retracted":true,"timestamp":1338854400000,"update":{"timestamp":null,"doi":null,"pmid":22707526,"type":"retraction"},"doi":"10.1124/jpet.111.190918","journal":"The Journal of pharmacology and experimental therapeutics","publisher":null,"title":"Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications."}
